Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens-Reference-Cited by-同舟云学术

Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens

Published:2016-03-21 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Arsenijevic Aleksandar,Milovanovic Marija,Milovanovic Jelena,Stojanovic Bojana,Zdravkovic Natasa,Leung Patrick S.C.,Liu Fu-Tong,Gershwin M. Eric,Lukic Miodrag L.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep23348.pdf

Reference63 articles.

1. Hsu, D. K., Chen, H. Y. & Liu, F. T. Galectin-3 regulates T-cell functions. Immunol Rev 230, 114–127, doi: 10.1111/j.1600-065X.2009.00798.x (2009).

2. de Oliveira, F. L. et al. Galectin-3 in autoimmunity and autoimmune diseases. Exp Biol Med 240, 1019–1028, doi: 10.1177/1535370215593826 (2015).

3. Jiang, H. R. et al. Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol 182, 1167–1173 (2009).

4. Mensah-Brown, E. P. et al. Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice. Clin Immunol 130, 83–88, doi: 10.1016/j.clim.2008.08.024 (2009).

5. Pejnovic, N. N. et al. Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 62, 1932–1944, doi: 10.2337/db12-0222 (2013).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Undifferentiated HepaRG cells show reduced sensitivity to the toxic effects of M8OI through a combination of CYP3A7-mediated oxidation and a reduced reliance on mitochondrial function;Food and Chemical Toxicology;2024-06

3. Galectin-3: therapeutic targeting in liver disease;Expert Opinion on Therapeutic Targets;2023-09-02

4. Inflammasome and pyroptosis in autoimmune liver diseases;Frontiers in Immunology;2023-03-08

5. Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver;Journal of Cellular Physiology;2023-02-06